Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04359836 · ClinicalTrials.gov registry record
A Study to Explore the Role of Gut Flora in COVID-19 Infection
A clinical trial of COVID-19 and Gut Microbiome, sponsored by ProgenaBiome.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04359836 is a study of COVID-19 and Gut Microbiome that is actively recruiting participants, run by ProgenaBiome. The registered enrollment target is 250 participants, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04359836, a study of COVID-19 and Gut Microbiome, is actively recruiting participants, sponsored by ProgenaBiome.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
Conditions Studied
Interventions
- OTHER There is no intervention in this study
Study Locations (1)
California
- ProgenaBiome - Ventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-04-16 |
| Est. Completion | 2027-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04359836
The ClinicalTrials.gov registry entry for NCT04359836 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is ProgenaBiome, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention in this study is the first listed.
NCT04359836 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04359836 about?
NCT04359836 is a clinical study titled "A Study to Explore the Role of Gut Flora in COVID-19 Infection". This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
What is the current status of trial NCT04359836?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2020-04-16. Estimated completion is 2027-07-31.
What conditions does trial NCT04359836 study?
This clinical trial studies the following conditions: COVID-19, Gut Microbiome, Coronavirus, Corona Virus Infection, COVID.
What interventions are being tested in trial NCT04359836?
The interventions under investigation include: There is no intervention in this study (OTHER).
Who is sponsoring clinical trial NCT04359836?
This trial is sponsored by ProgenaBiome, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04359836 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.